jueves, 19 de noviembre de 2026

Adjuvant Immunotherapy in High-Risk CSCC: What’s New, What’s Next, What Clinicians Need to Know Authors: Anna C. Pavlick, DO, MBA; Nina A. Ran, MD, MS, MPH

https://www.medscape.org/viewarticle/adjuvant-immunotherapy-high-risk-cscc-whats-new-whats-next-2026a10016zn?page=1&src=wnl_tpal_261118_mscpedu&uac=148436CN&impID=8916913

No hay comentarios:

Publicar un comentario